Delivery Order SPE2DB20D1050-SPE2DB25FH55J

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,347.31, is for the delivery of 4567640023 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.77 firm fixed-price delivery order is for the supply of 4564830160 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, with a completion date of June 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S medical supplies. The contract, valued at $1,884.96, is a delivery order with a firm fixed price and an ultimate completion date of January 18, 2024. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an award value of $1,221.51 and is for the delivery of 4567199444 - OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S to the Defense Logistics Agency (DLA). The $16,028.80 firm-fixed-price delivery order has an ultimate completion date of August 28, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S medical supplies. The award, valued at $1,494.51, was made by the Defense Logistics Agency (DLA) through a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of November 3, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.52, is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml containers. This is a firm fixed-price delivery order contract with a completion date of February 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.40 firm fixed-price delivery order is for the supply of OSELTAMIVIR PHOS 30 MG CAPSULE UD 10S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,784.25 firm fixed price delivery order is for the supply of 4567340215 - OSELTAMIVIR PHOS 30 MG CAPSULE UD 10S, with a performance period through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no major subcontractors...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,465.27, is for the delivery of Oseltamivir Phosphate 75 mg capsules. It is a Firm Fixed Price Delivery Order contract, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB20D1050
    Indefinite Delivery Contract
  • SPE2DB20D1050-SPE2DB25FH55J
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,092.85, is for the delivery of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/19/25, 9:49 AM